cbdmd inc - YCBD

YCBD

Close Chg Chg %
0.46 0.03 6.29%

Closed Market

0.49

+0.03 (6.29%)

Volume: 50.24K

Last Updated:

Nov 25, 2024, 3:39 PM EDT

Company Overview: cbdmd inc - YCBD

YCBD Key Data

Open

$0.46

Day Range

0.45 - 0.49

52 Week Range

0.42 - 1.73

Market Cap

$1.73M

Shares Outstanding

3.76M

Public Float

3.12M

Beta

1.99

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$7.88

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

164.69K

 

YCBD Performance

1 Week
 
2.06%
 
1 Month
 
-16.07%
 
3 Months
 
-11.82%
 
1 Year
 
-28.69%
 
5 Years
 
-99.68%
 

YCBD Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 1
Full Ratings ➔

About cbdmd inc - YCBD

cbdMD, Inc. engages in the business of operating cannabidiol brands such as Paw cannabidiol and cbdMD botanicals. Its product categories include CBD tinctures, gummies, topical, and bath bombs. The company was founded on March 17, 2015 and is headquartered in Charlotte, NC.

YCBD At a Glance

cbdMD, Inc.
8845 Red Oak Boulevard
Charlotte, North Carolina 28217
Phone 1-704-445-3060 Revenue 24.16M
Industry Pharmaceuticals: Other Net Income -22,938,209.00
Sector Health Technology Employees 52
Fiscal Year-end 09 / 2024
View SEC Filings

YCBD Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.087
Price to Book Ratio 0.339
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -0.628
Enterprise Value to Sales 0.165
Total Debt to Enterprise Value 0.925

YCBD Efficiency

Revenue/Employee 464,526.192
Income Per Employee -441,119.404
Receivables Turnover 19.863
Total Asset Turnover 0.848

YCBD Liquidity

Current Ratio 1.728
Quick Ratio 0.821
Cash Ratio 0.385

YCBD Profitability

Gross Margin 53.97
Operating Margin -38.371
Pretax Margin -94.961
Net Margin -94.961
Return on Assets -80.503
Return on Equity -113.399
Return on Total Capital -180.415
Return on Invested Capital -98.575

YCBD Capital Structure

Total Debt to Total Equity 40.779
Total Debt to Total Capital 28.967
Total Debt to Total Assets 22.74
Long-Term Debt to Equity 26.625
Long-Term Debt to Total Capital 18.902
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Cbdmd Inc - YCBD

Collapse All in section
All values USD millions. 2020 2021 2022 2023 5-year trend
Sales/Revenue
41.88M 44.48M 35.40M 24.16M
Sales Growth
+77.09% +6.20% -20.41% -31.77%
Cost of Goods Sold (COGS) incl D&A
15.51M 15.51M 14.90M 11.12M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
1.90M 2.25M 2.97M 2.93M
Depreciation
1.90M 2.21M 2.09M 1.53M
Amortization of Intangibles
- 48.48K 884.38K 1.40M
COGS Growth
+69.81% -0.01% -3.95% -25.38%
Gross Income
26.37M 28.97M 20.50M 13.04M
Gross Income Growth
+81.67% +9.86% -29.22% -36.42%
Gross Profit Margin
+62.96% +65.13% +57.91% +53.97%
2020 2021 2022 2023 5-year trend
SG&A Expense
43.95M 48.58M 37.81M 22.31M
Research & Development
- - - -
-
Other SG&A
43.95M 48.58M 37.81M 22.31M
SGA Growth
+52.21% +10.54% -22.17% -41.01%
Other Operating Expense
- - - -
-
Unusual Expense
(29.02M) 5.22M 53.08M 13.03M
EBIT after Unusual Expense
11.44M (24.84M) (70.39M) (22.30M)
Non Operating Income/Expense
(132.19K) 576.36K 310.92K (636.30K)
Non-Operating Interest Income
- 39.88K 16.25K 63.70K
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - 28.93K
-
Interest Expense Growth
- - - -
-
Gross Interest Expense
- - - 28.93K
-
Interest Capitalized
- - - -
-
Pretax Income
11.31M (24.29M) (70.08M) (22.94M)
Pretax Income Growth
+123.66% -314.84% -188.53% +67.27%
Pretax Margin
+26.99% -54.61% -197.96% -94.96%
Income Tax
- - (1.35M) (895.00K)
-
Income Tax - Current - Domestic
- - - -
-
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- - (1.35M) (895.00K)
-
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
12.65M (23.39M) (70.08M) (22.94M)
Minority Interest Expense
- - - -
-
Net Income
12.65M (23.39M) (70.08M) (22.94M)
Net Income Growth
+127.85% -284.92% -199.57% +67.27%
Net Margin Growth
+30.21% -52.60% -197.96% -94.96%
Extraordinaries & Discontinued Operations
- - - (48.98K)
-
Discontinued Operations
- - - (48.98K)
-
Net Income After Extraordinaries
12.60M (23.39M) (70.08M) (22.94M)
Preferred Dividends
366.85K 2.55M 4.00M 4.00M
Net Income Available to Common
12.24M (25.95M) (74.09M) (26.94M)
EPS (Basic)
12.4736 -21.2553 -55.7964 -13.3214
EPS (Basic) Growth
+109.83% -270.40% -162.51% +76.12%
Basic Shares Outstanding
980.90K 1.22M 1.33M 2.02M
EPS (Diluted)
12.1887 -21.2553 -55.7964 -13.3214
EPS (Diluted) Growth
+109.61% -274.39% -162.51% +76.12%
Diluted Shares Outstanding
1.00M 1.22M 1.33M 2.02M
EBITDA
(15.68M) (17.36M) (14.34M) (6.34M)
EBITDA Growth
-11.44% -10.72% +17.41% +55.78%
EBITDA Margin
-37.44% -39.03% -40.51% -26.25%

Snapshot

Average Recommendation BUY Average Target Price 2.00
Number of Ratings 1 Current Quarters Estimate -0.37
FY Report Date 12 / 2024 Current Year's Estimate -0.89
Last Quarter’s Earnings -0.45 Median PE on CY Estimate N/A
Year Ago Earnings -2.63 Next Fiscal Year Estimate N/A
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 1 1 1 N/A
Mean Estimate -0.37 -0.36 -0.89 N/A
High Estimates -0.37 -0.36 -0.89 N/A
Low Estimate -0.37 -0.36 -0.89 N/A
Coefficient of Variance N/A N/A N/A N/A

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 1 1 1
OVERWEIGHT 0 0 0
HOLD 0 0 0
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Cbdmd Inc in the News